The prosthetic heart valve market is projected to reach USD 8.86 Billion by 2022 from USD 4.84 Billion in 2017, at a CAGR of 12.9%

Download FREE Brochure  @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=245407958


Market growth can be attributed to the rising geriatric population and the subsequent increase in the prevalence of HVD, regulatory approvals for new and advanced prosthetic heart valve, increasing government funding for heart valve research, rising awareness about HVD, and favorable reimbursement scenario for prosthetic heart valve.


**Top Key Players**
A majority of the leading players in prosthetic heart valve market (https://www.marketsandmarkets.com/Market-Reports/prosthetic-heart-valve-market-245407958.html) are focusing on marketing and promotional activities, product launches and approvals, acquisitions, agreements, collaborations, and expansions to enhance their market presence and strengthen their distribution networks, cater to the needs of a growing customer base, widen their product portfolios, and boost their production capabilities. 


Edwards Lifesciences Corporation (U.S.), Medtronic plc (Ireland), and St. Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.) are identified as the top players in this market. These companies have a diversified product portfolio, wide geographic reach, and a strong focus on innovation and research.


North America is expected to dominate the prosthetic heart valve market, followed by Europe, Asia-Pacific, and the RoW. North America is also expected to register the highest CAGR during the forecast period. The large share and high growth in this regional segment can be attributed to factors such as the rapid growth in the aging population and prevalence of valvular heart diseases, favorable reimbursement scenario, and rising product approvals for heart valve are contributing to the growth of the North American prosthetic heart valve market.

Target Audience for this Report:

Prosthetic Heart Valve Manufacturing Companies
Suppliers and Distributors of Prosthetic Heart Valve
Healthcare Service Providers
Teaching Hospitals and Academic Medical Centers (AMCs)
Health Insurance Players
Research and Consulting Firms
Medical Research Institutes

Read More  @ https://www.marketsandmarkets.com/PressReleases/prosthetic-heart-valve.asp